Introduction
Helicobacter pylori is a motile, spiral-shaped, and microaerophilic Gram-negative bacterium, adapted to colonize and survive in the stomach mucosa; it is believed to colonize more than 50% of the world pop ulation.1-3 Although H. pylori generally survives within the gastric mucus layer, it can attach to host cells. H. pylori can use at least five different adhesins for suc cessful attachment to gastric epithelial cells. Adaptation requires expression of several adhesins and of a potent urease to neutralize the gastric acidity by producing ammonia from urea present in mucosal secretions. 4, 5 H. pylori is believed to be a major cause of chronic active gastritis, peptic ulcer, and atrophic gastritis; it is associated with an increased risk of gastric adenocarci noma and mucosa-associated lymphoid tissue (MALT) lymphoma. H. pylori infection is responsible for human diseases, is mostly acquired in childhood and persists chronically when untreated. The persistent H. pylori infection results in the induction of an inflammatory response and epithelial cell damage, which is man ifested histologically as chronic superficial gastritis. Al though most infections remain asymptomatic, about 10% of H. pylori-infected people become ill, suffer ing from peptic ulcer, gastric adenocarcinoma, and/or MALT lymphoma, years or decades later.6 Intracellular vacuolization has been observed by electron microscopy of gastric epithelial cells from pa tients with chronic gastritis infected with H. pylori.7,8 H. pylori produces and secretes a potent protein toxin, the vacuolating cytotoxin, VacA, which induces cyto plasmic vacuolation and apoptosis, leading to gastric injury. Before VacA purification, an immunodominant protein encoded in the cagA gene, which is located on the border of a pathogenicity island of H. pylori, was mistaken for VacA. Although recent work showed that the CagA, which is injected by its type IV secretion system and tyrosine phosphorylated in host cells,9-11 forms a complex with SHP-2 tyrosine phosphatase,12 the function of CagA is still unknown. Type-I strains, which produce both VacA and CagA, are considered more pathogenic and are more likely than the type-II strains lacking VacA activity and the pathogenicity island to be associated with the severe diseases (e . g., ulceration, adenocarcinoma).13 Oral administration of VacA causes gastric mucosal damage in mice14-17 and VacA has been proven epidemiologically to be a viru lence factor associated with peptic ulcer in humans .18,19 Incubation of VacA at pH 2 increased its vacuolat ing activity, and its resistance to acid and pepsin deg radation. It was notable that acid-activated VacA contributed to the development of duodenal lesions, independent of H. pylori.30 In addition, VacA was activated, not only under acidic, but also alkaline con ditions resulting in its enhanced binding to target cells.31 Although the detailed mechanism is the subject of much speculation, taken together with the recent re port on tertiary structure of VacA, the acid-and alkali activation of VacA might reflect a molecular change from hexamer to heptamer, resulting in exposure of some portion of the protein surface needed for receptor binding.31 H. pylori persistently grows in the mucus layer of the gastric tissue by means of a potent urease which produces ammonia; this product plays a signifi cant role in the neutralization of the acidic environment of the stomach and allows the bacteria to adhere to the apical plasma membrane of surface epithelial cells in the pyloric antrum in vivo. In vitro H. pylori adhered to AGS human gastric adenocarcinoma cells; H. pylori appeared to be partially engulfed by the plasma mem brane which was associated with a loosely organized network of actin filaments. 
